These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 15667140)

  • 1. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM; Haupt S; Stuppner H; Langer T
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors.
    Barreca ML; De Luca L; Iraci N; Rao A; Ferro S; Maga G; Chimirri A
    J Chem Inf Model; 2007; 47(2):557-62. PubMed ID: 17274611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast and efficient in silico 3D screening: toward maximum computational efficiency of pharmacophore-based and shape-based approaches.
    Kirchmair J; Ristic S; Eder K; Markt P; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2007; 47(6):2182-96. PubMed ID: 17929799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors.
    Murcia M; Ortiz AR
    J Med Chem; 2004 Feb; 47(4):805-20. PubMed ID: 14761183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
    Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
    Kim J; Kim KS; Kim DE; Chong Y
    Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S; Schneider G
    J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
    Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
    J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
    Ye Y; Liao Q; Wei J; Gao Q
    Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
    Franke L; Schwarz O; Müller-Kuhrt L; Hoernig C; Fischer L; George S; Tanrikulu Y; Schneider P; Werz O; Steinhilber D; Schneider G
    J Med Chem; 2007 May; 50(11):2640-6. PubMed ID: 17461565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
    Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
    Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.